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The combination of psoralens and UVA radiation (PUVA
photochemotherapy) is an established treatment for many
skin disorders. UVA-induced psoralen–DNA interactions
are assumed to contribute to the cutaneous anti-inflam-
matory and anti-proliferative effects of PUVA. PUVA-
induced DNA modifications might interfere not only
with DNA replication, but also with gene transcription
of proinflammatory genes. We therefore studied the effect
of PUVA on cell proliferation and on the transcription
of the c-jun and intercellular adhesion molecule-1 genes
in a promyelocytic (HL60) and a keratinocyte (HaCaT)
cell line. PUVA inhibited cell proliferation increasingly
with increasing 8-methoxypsoralen concentrations or
UVA doses. The inhibition was observed at conditions
not affecting cell viability up to 48 h after PUVA. In
contrast, PUVA did not inhibit gene transcription at
anti-proliferative, yet nonlethal conditions. Baseline and
The combination of psoralens with UVA radiation (PUVAphotochemotherapy) has been used for more than 20 yto treat psoriasis and several other skin diseases (Parrishet al, 1974; Honig et al, 1994; Lu¨ftl et al, 1997).The exact molecular mechanisms responsible for the
therapeutic efficacy of PUVA are still a matter of debate. It is generally
believed that DNA modifications may represent one therapeutic mode
of action. Psoralens intercalate DNA. UVA induces the formation of
psoralen-DNA photoadducts in direct photochemical reactions
(oxygen-independent type I reaction) that may result in cross-linking
of the DNA double helix and inhibition of DNA replication (Song
and Tapley, 1979). Additional DNA modifications may indirectly result
from the generation of intracellular reactive oxygen intermediates
(ROI) by PUVA (oxygen-dependent type II reaction) (Ho¨nigsmann
et al, 1993).
PUVA-induced psoralen-DNA photoadducts inhibit cell prolifera-
tion. Interference with DNA synthesis has been demonstrated in the
skin in vivo (Walter et al, 1973; Epstein and Fukuyama, 1975; Fritsch
et al, 1979) and in dermatologically relevant cell types in vitro, including
fibroblasts (Baden et al, 1972; Cohen et al, 1981), keratinocytes (Tokura
et al, 1991; Vallat et al, 1994), melanocytes (Kao and Yu, 1992), or
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phorbol-ester induced c-jun mRNA expression was not
inhibited, nor was baseline and IFN-g or phorbol-ester
induced intercellular adhesion molecule-1 mRNA expres-
sion. In order to assess possible transcriptional effects
of PUVA-generated reactive oxygen intermediates, the
reactive oxygen intermediates-sensitive transcription fac-
tor nuclear factor kB was assayed in mobility shift experi-
ments. Nuclear factor kB-specific binding activity was
not induced 1–24 h after PUVA in extracts from PUVA-
treated cells when compared with controls, whereas the
pro-oxidant cytokine TNF-a caused a marked increase
in nuclear factor kB binding. The presented data suggest
that PUVA inhibits cell proliferation, but not transcrip-
tion, at nonlethal PUVA conditions. Furthermore, the
data do not support a major role for PUVA-generated
reactive oxygen intermediates in the regulation of gene
transcription. Key words: epithelial cells/inflammation/photo-
biology/psoralens. J Invest Dermatol 111:399–405, 1998
leukocytes (Scherer et al, 1977; Morison et al, 1981; Kraemer, 1982).
At low doses, PUVA-induced growth inhibition may be fully reversible
and may not affect cell viability (Kao and Yu, 1992). At somewhat
higher doses, however, PUVA also induces apoptosis and cell necrosis
(Marks and Fox, 1991; Yoo et al, 1996).
In addition to interfering with DNA replication, PUVA may also
affect the transcription of genes, if the photoadducts are located at
promoters or transcribed gene segments. Inflammatory diseases could
thus be ameliorated by inhibiting the expression of proinflammatory
cytokines or adhesion molecules. Studies addressing the effect of PUVA
on gene expression have so far produced divergent results. Both
inhibitions (Tokura et al, 1991; Neuner et al, 1994) and increases
(Moor et al, 1995; Bernstein et al, 1996; Mohamadzadeh et al, 1996)
of gene expression have been reported.
In this study we have investigated the effects of PUVA on DNA
replication and promoter function at dosages not affecting cell viability,
and show that in such a situation PUVA results in the inhibition of
cell proliferation, but not in the inhibition of gene transcription.
MATERIALS AND METHODS
Cell culture and reagents The human promyelocytic leukemia cell line
HL60 was obtained from American Type Culture Collection (Rockville, MD).
The spontaneously immortalized, nontumorigenic keratinocyte-derived cell line
HaCaT was a kind gift from N. Fusenig (DKFZ, Heidelberg, Germany)
(Boukamp et al, 1988). Cells were cultured in Dulbecco’s modified Eagle’s
medium (HaCaT) or RPMI 1640 (HL60) supplemented with 2 mM
L-glutamine, antibiotics (100 U penicillin per ml and 100 µg streptomycin per
ml), 1 µg amphotericin B per ml (all from Gibco/BRL, Eggenstein, Germany),
and 10% fetal calf serum (Biochrom, Berlin, Germany), at 37°C and 5% CO2.
In some experiments, IFN-γ, TNF-α (both Pharma Biotechnologie, Hannover,
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Germany), or the phorbol ester phorbol-12-myristate-13-acetate (PMA; Sigma,
Deisenhofen, Germany) were added to cultures. Crystalline 8-methoxypsoralen
(8-MOP; Gerot, Vienna, Austria) was dissolved in absolute ethanol at a
concentration of 1 mg per ml. This stock solution was always kept in the dark
and used for appropriate dilutions for experiments.
PUVA treatment PUVA treatment of cells was carried out using 8-MOP
and UVA irradiation. Cells were preincubated in Petri dishes at varying
concentrations of 8-MOP in culture medium at 37°C for 30 min in the dark
until immediately before irradiation. During irradiation Petri dishes were floated
in a water bath at 37°C for temperature control. Dishes were kept at a fixed
location by a rack whose poles extended above water level. UVA was applied
with a PUVA 200 light arch (Waldmann, Villingen-Schwenningen, Germany)
containing 14 F8T5 PUVA bulbs, whose emission spectrum is mainly between
315 and 365 nm. The energy output was determined by a UV meter (Waldmann)
and was 3.8 mW per cm2 at a 28 cm source to target distance. Irradiation times
were calculated for the desired range of UVA dosages and were corrected for
the loss of energy caused by the passage of radiation through the medium.
Immediately after irradiation, cells were provided with fresh medium and
incubated at 37°C and 5% CO2 for varying time periods. Unirradiated controls
were removed from the incubator during irradiation procedures, but kept from
UV exposure.
Proliferation assay For assessment of PUVA effects on proliferative activity,
10,000 HaCaT or 30,000 HL60 cells were seeded in 96 well plates in
quadruplicates in 100 µl culture medium. Immediatly after PUVA 0.5 µCi
[3H]thymidine (New England Nuclear, Bad Homburg, Germany) was added
to treated cells and to untreated control cells. After 24 h, cells were washed,
harvested, and [3H]thymidine incorporation into newly synthesized DNA was
determined by scintillation counting.
Isolation of mRNA and northern blot analysis Total cellular RNA was
isolated by guanidinium isothiocyanate lysis, acid phenol extraction, and
isopropyl alcohol precipitation. Subsequently, the RNA was size-fractioned by
formaldehyde/agarose gel electrophoresis and blotted to nylon membranes as
described (Sambrook et al, 1989). A 1.2 kb Sal I-Kpn I-fragment of an
intercellular adhesion molecule (ICAM)-1 cDNA clone (kindly provided by
D. Staunton, Dana-Farber Cancer Institute, Boston, MA) and a 1.1 kb fragment
of c-jun c-DNA (kindly provided by G. Messer, Department of Dermatology,
Ludwig-Maximilians University, Munich, Germany) (Kick et al, 1996) were
radiolabeled with [32P]-dCTP (Hartmann, Braunschweig, Germany) via random
hexamer primer extension and used as hybridization probes. As a control probe
for loading uniformity, a 0.21 kb PCR product amplified from a human
glyceraldehyde-3-phosphate dehydrogenase cDNA was used as previously
described (Behrends et al, 1994). Prehybridization and hybridization were
carried out at 42°C in 50% formamide, 1 M NaCl, 10% dextran, 1% sodium
dodecyl sulfate, 100 µg per ml yeast tRNA, and 10 mg per ml Salmon sperm
DNA. After hybridization overnight, nylon membranes were washed under
increasingly stringent salt conditions and autoradiography was performed using
XAR-5 films with one intensifying screen at –70°C.
Immunofluorescence flow cytometry ICAM-1 cell surface expression was
assessed by a one step staining procedure and subsequent immunofluorescence
flow cytometry (FACS analysis). Untreated or PUVA-treated cells were incub-
ated with a fluoroscein isothiocyanate-coupled murine anti-human ICAM-1
monoclonal antibody (Bender Med Systems, Vienna, Austria) or with an
fluoroscein isothiocyanate-coupled isotype-matched control monoclonal anti-
body (mouse IgG1, Dianova, Hamburg, Germany). Subsequently, cells were
analyzed in a FACScan II flow cytometer using the Lysis II analysis program
(Becton Dickinson, Heidelberg, Germany).
Assessment of cell viability As a parameter for cell viability, cell membrane
permeability was assessed at varying time points after PUVA by dye-exclusion
experiments (trypan blue and propidium iodide staining). Propidium iodide
staining was assessed by flow cytometry as described previously (Behrends et al,
1994). Briefly, 50 ng propidium iodide (Sigma) were added to cells and FACS
analysis performed for the distinction of viable (propidium iodide negative)
from dead (propidium iodide positive) cells.
Preparation of nuclear extracts Nuclear extracts were prepared as previ-
ously described (Ausubel et al, 1989). Briefly, cells were kept in serum-free
medium 16 h prior to lysis. Nuclei were isolated either from untreated control
cells, from PUVA treated cells at various time points after treatment, or from
cells stimulated with TNF-α. Protein content of extracts was quantitated
photometrically using the Coomassie protein assay reagent (Pierce, Rochford,
Ill). Extracts were normalized for protein concentration prior to analysis.
Electrophoretic mobility shift assays Nuclear extracts from HL60 or
HaCaT cells were incubated with 32P-radiolabeled DNA fragments. The
incubation was carried out in a 20 µl reaction containing 0.225 mg bovine
serum albumin per ml (Sigma), 0.2 mg poly dI/dC per ml (Pharmacia, Uppsala,
Sweden), 12 mM HEPES, 4 mM Tris (pH 7.9), 100 mM KCl, 1 mM
ethylenediamine tetraacetic acid, 1 mM dithiothreitol, 12.5% (wt/vol) glycerol.
A blunt ended double-stranded oligonucleotide containing a consensus-binding
sequence for nuclear factor κB (NFκB) that is identical to the NFκB-binding
sites of HIV-1 (top strand 59AGTTGAGGGGACTTTCCCAGGC, binding
sequence displayed in bold letters; Promega, Madison, WI) was labeled with
[γ-32P] adenosine triphosphate (Hartmann) as previously described (Mueller et al,
1995). For competition studies an unlabeled double-stranded oligonucleotide
containing a consensus-binding sequence for AP1 (top strand 59 CGCTTGAT-
GAGTCAGCCGGAA, binding sequence displayed in bold letters; Promega)
was used. Additionally, a blunt ended double-stranded oligonucleotide con-
taining a consensus-binding sequence for SP1 (top strand 59 ATTCGATCGGG-
GCGGGGCGAGC, binding sequence displayed in bold letters; Promega) was
used. DNA-protein-binding complexes were resolved by electrophesis on
nondenaturing 5% polyacrylamide gels in a high ionic strength glycine (14.3%
wt/vol) running buffer. Gels were run at 12 V per cm for 2 h, dried, and
exposed to Kodak XAR-5 film at –70°C with one intensifying screen.
RESULTS
Establishment of nonlethal PUVA conditions In order to establish
a range of psoralen concentrations and UVA dosages that would allow
us to study cellular PUVA effects without destroying the investigated
cell lines, viability of PUVA-treated cells was analyzed by propidium
iodide incorporation 24 h and 48 h after PUVA and compared with
untreated controls (Table I). At 500 ng 8-MOP per ml, cell viability
was not reduced after 24 h, when up to 0.25 J per cm2 (HL60) or up
to 1 J per cm2 (HaCaT) UVA were applied. UVA doses not reducing
viability 48 h after PUVA were only slightly lower, i.e., 0.125 J per
cm2 (HL60) and 0.5 J per cm2 (HaCaT). In HL60 cells reduction of
the 8-MOP concentration from 500 ng per ml to 100 ng per ml
increased the lowest UVA dose not affecting viability 4-fold from
0.125 to 0.5 J per cm2 at 24 h post-PUVA (Table I). Treatment with
either 8-MOP (up to 1000 ng per ml) or UVA (up to 5 J per cm2)
alone did not affect cell viability (data not shown). Analysis of cell
viability by trypan blue staining gave concordant results.
PUVA inhibits cell proliferation at nonlethal conditions PUVA-
induced DNA-psoralen photoadducts are assumed to inhibit cell
proliferation by interference with DNA replication. As a read out for
PUVA inhibition of DNA replication, proliferative activity was meas-
ured as [3H]thymidine incorporation. Proliferation of HL60 and HaCaT
cells was markedly inhibited 24 h after PUVA (Fig 1A, B). Inhibition
increased with increasing UVA dosages and was also influenced by the
psoralen concentration. When the 8-MOP concentration was reduced,
a higher UVA dose was required to achieve a similar inhibition of cell
proliferation in HL60 cells (Fig 1A). When cells were incubated with
500 ng 8-MOP per ml, a 50% inhibition of proliferation was achieved
with 0.125 J UVA per cm2 in HL60 cells and with 0.25 J UVA per
cm2 in HaCaT cells. Thus, proliferation of HL60 and HaCaT cells
was markedly inhibited at PUVA conditions not affecting viability of
the respective cell line (Table I). Treatment with 8-MOP (500 ng per
ml) or UVA (1 J per cm2) alone did not affect proliferative activity.
PUVA does not inhibit baseline and induced c-jun and ICAM-1
mRNA expression at nonlethal conditions In order to explore
the possibility that PUVA-induced psoralen-DNA photoadducts not
only interfere with DNA replication, but also with the transcription
of proinflammatory genes at their promoters or at transcribed gene
segments, the effects of PUVA on mRNA expression of the immediate
early gene c-jun and the adhesion molecule ICAM-1 were studied.
The expression of both molecules in response to various inducers is
strongly regulated at the transcriptional level (Stein et al, 1992; Van de
Stolpe and Van der Saag, 1996).
Untreated HL60 cells displayed a low baseline c-jun mRNA
expression that was not altered by treatment with 8-MOP (500 ng per
ml) or UVA (0.25 J per cm2) alone (Fig 2). PUVA effects on mRNA
levels were assessed 2 h and 6 h after PUVA. At treatment conditions
that markedly inhibit proliferative activity (500 ng 8-MOP per ml,
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Table I. Effect of PUVA on cell viabilitya
HL 60 HL 60 HaCaT
100 ng 8-MOP per mlc 500 ng 8-MOP per ml 500 ng 8-MOP per ml
24 h 48 h 24 h 48 h 24 h 48 h
post-PUVA post-PUVA post-PUVA post-PUVA post-PUVA post-PUVA
no UVA 85 89 97 94 95 97
0.05b ND ND 95 95 ND ND
0.125 80 87 98 83 92 97
0.25 80 85 96 17 94 96
0.5 76 41 26 12 91 86
1.0 69 18 ND ND 93 69
2.0 ND ND ND ND 79 43
aCell viability expressed as the percentage (%) of propidium-iodide negative cells determined as described in Materials and Methods.
bUVA-irradiation dose in J per cm2.
cCells treated with 8-MOP as described in Materials and Methods.
0.25 J UVA per cm2), PUVA did not reduce baseline c-jun mRNA
expression (Fig 2). Rather, a slight mRNA induction was observed
6 h after PUVA. A negative interference of PUVA with transcription
might become more obvious in an actively transcribing promoter
compared with a promoter with a low baseline activity. Therefore,
HL60 cells were treated with PMA, a known inducer of c-jun
transcription (Stein et al, 1992), immediately after PUVA. PMA strongly
increased the c-jun mRNA level (Fig 2); similar to baseline expression,
PMA-induced c-jun mRNA expression was not inhibited by PUVA
at conditions that reduce proliferative activity (500 ng 8-MOP per ml,
0.25 J UVA per cm2).
Untreated HL60 cells displayed a low baseline ICAM-1 mRNA
expression, which was not altered by treatment with 8-MOP (500 ng
per ml) or UVA (0.25 J per cm2) alone (Fig 3A). PUVA did not
decrease this baseline ICAM-1 mRNA expression at conditions that
markedly reduce proliferation (500 ng 8-MOP per ml, 0.25 J UVA
per cm2). In order to assess PUVA effects in the situation of a strongly
transcribed ICAM-1 gene, ICAM-1 transcription was induced by
treating HL60 cells with either IFN-γ (100 U per ml) or PMA (100 ng
per ml) immediately after PUVA. IFN-γ and PMA are both inducers
of ICAM-1 transcription (Look et al, 1994; Mueller et al, 1995).
ICAM-1 mRNA expression was strongly increased by IFN-γ or PMA
(Fig 3A). PUVA did not antagonize this induction at conditions that
reduce proliferative activity (500 ng 8-MOP per ml, 0.25 J UVA per
cm2). Similarly, PUVA also did not inhibit baseline and IFN-γ induced
ICAM-1 mRNA expression in the keratinocyte cell line HaCaT
(Fig 3B). In summary, no inhibitory PUVA effect on gene transcription
was observed at anti-proliferative conditions.
PUVA does not inhibit baseline and induced ICAM-1 cell
surface expression at nonlethal conditions In addition to the
assessment of PUVA effects on ICAM-1 mRNA expression, ICAM-1
cell surface expression was studied by flow cytometry in HaCaT cells
(Fig 4). The baseline ICAM-1 cell surface expression in HaCaT cells
was not reduced 24 h after PUVA (500 ng 8-MOP per ml and UVA
dosages ranging from 0.05 to 0.5 J per cm2). ICAM-1 expression was
markedly induced by 100 U IFN-γ per ml, and this upregulation was
not antagonized by PUVA at strongly anti-proliferative conditions
(500 ng 8-MOP per ml and UVA dosages ranging from 0.25 to 0.5 J
per cm2, applied immediately before IFN-γ). Similar results were
observed in HL60 cells both for baseline and for IFN-γ induced
ICAM-1 cell surface expression (data not shown).
PUVA does not activate DNA binding of NFkB at nonlethal
conditions Besides direct interference with transcription at pro-
moters, PUVA may also affect gene expression indirectly by generating
ROI (Potapenko, 1991), which in turn may activate transcription
factors and modulate transcription. The effect of PUVA on the activity
of the ROI-activated transcription factor NFκB (Meyer et al, 1993)
was representatively investigated. A double-stranded oligonucleotide
probe containing an NFκB consensus-binding site was tested in
electrophoretic mobility shift assays against nuclear extracts prepared
from untreated or PUVA-treated HaCaT or HL60 cells. The NFκB
consensus-binding site binds a slower migrating p50/p65 heterodimer
and a faster migrating p50 homodimer (Baeuerle and Henkel, 1994).
In HaCaT cells, baseline DNA–protein complexes were observed
when extracts from untreated cells were used (Fig 5a). No clearly
enhanced binding was observed in extracts from cells treated with 8-
MOP (500 ng per ml for 1 h) or with UVA alone (1 J per cm2, cell
extracts prepared 1 h after irradiation). No increased NFκB binding
was noted 1 h after PUVA either at anti-proliferative, yet nonlethal,
PUVA conditions (500 ng 8-MOP per ml; 0.5 J UVA per cm2) or at
PUVA conditions that are even cytotoxic for HaCaT (500 ng 8-MOP
per ml; 1.0 J UVA per cm2) (Fig 5a). Additionally, no NFκB activation
was observed 3 h and 24 h after PUVA (data not shown). In contrast,
in extracts from cells treated with the pro-oxidant cytokine TNF-α
(extract preparation 1 h after addition of 10 ng TNF-α per ml), a
marked increase in DNA–protein complex (p65 heterodimer) formation
was noted. Similar results were obtained in HL60 cells (Fig 5a):
baseline DNA–NFκB complexes were not increased 1 h after treatment
with PUVA schedules that are anti-proliferative (100 ng 8-MOP per
ml; 0.5 J UVA per cm2) or even cytotoxic (500 ng 8-MOP per ml;
0.5 J UVA per cm2) after 24 h; however, TNF-α (10 ng per ml) again
markedly increased specific NFκB binding.
The specificity of the observed NFκB-binding complexes was
verified by competition studies. The binding complexes could be
competed away using excess unlabeled identical double-stranded
NFκB-oligonucleotide; however, the binding was unaffected by the
presence of excess unlabeled double-stranded oligonucleotide with an
irrelevant sequence (AP1 consensus-binding motif) (Fig 5b). Nuclear
extracts were also reacted with a double-stranded oligonucleotide
probe incorporating a consensus sequence for the transcription factor
SP1 (Fig 5a). SP1-binding activity was unchanged among all extracts,
making it unlikely that the observed NFκB-binding activity pattern
reflects differences in extract composition or preparation. Taken
together, no evidence for NFκB activation by PUVA was found.
DISCUSSION
In this study we show that PUVA inhibits DNA replication, but not
gene transcription, at nonlethal conditions. No evidence for the
activation of the ROI-sensitive transcription factor NFκB was found,
suggesting that PUVA may not produce enough ROI to effectively
modulate transcription at nonlethal conditions.
We have observed a strong anti-proliferative effect at PUVA condi-
tions that are well within the range of anti-proliferative PUVA
conditions reported for myeloid cells (Morison et al, 1981; Gasparro
et al, 1984) or keratinocytes (Tokura et al, 1991; Vallat et al, 1994).
Importantly, the chosen PUVA conditions are nonlethal and close to
the range that is regarded to be clinically relevant (10–500 ng 8-MOP
per ml; 0.5–2 J UVA per cm2) (Bernstein et al, 1996; Johnson et al, 1996).
The cellular events responsible for the therapeutic benefit of PUVA
are not fully understood. It is generally assumed that UVA-induced
DNA-psoralen photoadducts (type-I reactions) impede replication,
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Figure 1. PUVA inhibits proliferation of HL60 and HaCaT cells.
Proliferative activity of HL60 (A) and HaCaT (B) cells 24 h after PUVA
measured as [3H]thymidine incorporation as described in Materials and Methods.
Results are expressed as percentage of proliferative activity of untreated control
cells. One representative out of two (HL60) or four (HaCaT) experiments
is shown.
leading to the inhibition of cell proliferation. PUVA-mediated inhibi-
tion of proliferation may be beneficial in psoriasis both with regard to
hyperproliferative epidermal keratinocytes (reduction of acanthosis)
and with regard to interference with the expansion of skin infiltrating
T cells sustaining inflammation. As demonstrated in this study, inhibition
of proliferation can be observed at PUVA conditions not significantly
affecting cell viability, confirming previous observations (Vallat et al,
1994; Johnson et al, 1996). On the other hand, higher UVA doses
and psoralen concentrations may lead to irreversible cell damage.
Lymphocytes are especially susceptible to PUVA-induced apoptosis
and necrosis (Marks and Fox, 1991; Johnson et al, 1996), and lymphocyte
death may considerably contribute to the anti-inflammatory effect of
PUVA in psoriasis and to the decrease of skin infiltration with tumor
cells in cutaneous T cell lymphomas (Johnson et al, 1996; Yoo et al,
Figure 2. PUVA does not inhibit baseline or induced c-jun mRNA
expression. Total cellular RNA was isolated from untreated HL60 cells and
from HL60 cells 2 and 6 h after PUVA. Additionally, cells were incubated with
100 ng PMA per ml for 2 and 6 h either as the sole treatment or immediately
after PUVA. RNA was electrophoresed and analyzed by northern blot
hybridization using a [32P]-labeled c-jun cDNA probe. A PCR product
amplified from a glyceraldehyde-3-phosphate dehydrogenase cDNA (GAPDH)
is shown as a control for loading uniformity. Lane 1, untreated control cells;
lane 2, 500 ng per ml 8-MOP; lane 3, 0.25 J UVA per cm2; lane 4, PUVA
(500 ng 8-MOP per ml 1 0.05 J UVA per cm2); lane 5, PUVA (500 ng 8-
MOP per ml 1 0.25 J UVA per cm2); lane 6, PMA; lane 7, PUVA (500 ng 8-
MOP per ml 1 0.05 J UVA per cm2) 1 PMA; lane 8, PUVA (500 ng 8-
MOP per ml 1 0.25 J UVA per cm2) 1 PMA.
1996). In addition to direct cutaneous actions, PUVA may affect the
course of skin diseases by yet other mechanisms, as suggested by the
efficacy of extracorporeal photopheresis in treating cutaneous T cell
lymphoma and the potential of PUVA to systemically suppress contact
hypersensitivity in mice (Kripke et al, 1983).
PUVA-induced DNA-psoralen photoadducts may not only inhibit
DNA replication, but may also interfere with gene transcription. The
principal ability of psoralens to inhibit RNA transcription via UVA-
catalyzed covalent binding to template DNA has been demonstrated
in cell free transcription assays (Song and Tapley, 1979). Few data,
however, exist regarding inhibitory effects of PUVA on cellular transcrip-
tion. Reductions of total cellular RNA synthesis (Heimer et al, 1978;
Nielsen and Linnane, 1983) and of cytokine gene expression (Neuner
et al, 1994) have been reported. In these studies, however, psoralen
concentrations and UVA dosages were much higher than those used
here and are expected to cause significant apoptosis and cell necrosis.
Thus, the observed inhibitory effect may reflect increased cell death.
A major aim of this study was to identify inhibitory PUVA effects on
gene transcription at pharmacologically relevant, i.e. anti-proliferative,
yet nonlethal, treatment conditions. At such conditions, only a few
psoralen photoadducts per million base pairs are expected. In an
experiment in murine keratinocytes using PUVA conditions (100 ng
8-MOP per ml and 1.0 J UVA per cm2) that are comparable with
those used in this study, 3.8 psoralen-DNA photoadducts per million
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Figure 3. PUVA does not inhibit baseline or induced ICAM-1 mRNA
expression. (A) Total cellular RNA was isolated from untreated HL60 cells
and from treated cells 6 h after PUVA. Additionally, cells were incubated with
100 ng PMA per ml or 100 U IFN-γ per ml immediately after PUVA. RNA
was electrophoresed and analyzed by northern blot hybridization using a [32P]-
labeled ICAM-1 cDNA probe. A PCR product amplified from a glyceraldehyde-
3-phosphate dehydrogenase cDNA (GAPDH) is shown as a control for loading
uniformity. Lane 1, untreated control cells; lane 2, 500 ng 8-MOP per ml; lane
3, 0.25 J UVA per cm2; lane 4, PUVA 500 ng 8-MOP per ml 1 0.05 J UVA
per cm2; lane 5, PUVA 500 ng 8-MOP per ml 1 0.25 J UVA per cm2; lane 6,
IFN-γ; lane 7, PUVA (500 ng 8-MOP per ml 1 0.25 J UVA per cm2) 1 IFN-
γ; lane 8, untreated control cells; lane 9, PMA; lane 10, PUVA (500 ng 8-
MOP per ml 1 0.25 J UVA per cm2) 1 PMA. (B) Total cellular RNA was
isolated from untreated and from PUVA-treated HaCaT cells 6 h after PUVA.
Lanes 1 and 2, untreated control cells; lane 3, PUVA 500 ng 8-MOP per ml
1 0.05 J UVA per cm2; lane 4, PUVA (500 ng 8-MOP per ml 1 0.25 J UVA
per cm2); lane 5, PUVA (500 ng 8-MOP per ml 1 1.0 J UVA per cm2); lane
6, IFN-γ; lane 7, PUVA (500 ng 8-MOP per ml 1 1.0 J UVA per cm2) 1 IFN-γ.
Figure 4. PUVA does not inhibit baseline and induced ICAM-1 cell
surface expression in HaCaT cells. Analysis by immunofluorescence flow
cytometry as described under Materials and Methods using an IgG1 isotype
control (IGG1) and an anti-ICAM-1 monoclonal antibody (ICAM-1). PUVA
conditions were 500 ng 8-MOP per ml and 0.5 J UVA per cm2. (A) Analysis
of untreated (CONTROL) and treated (PUVA) cells 24 h after PUVA. (B)
Analysis of HaCaT cells treated with 100 U IFN-γ per ml either as the sole
treatment (IFN-G) or immediately after PUVA (PUVA 1 IFN-G). One
representative of five experiments is displayed.
base pairs were recorded (Tokura et al, 1991). PUVA treatments result
in 8-MOP-DNA photoadducts in the range of one per million base
pairs in the skin of psoriasis patients (Santella et al, 1988). This may
already negatively affect cell division, because a single psoralen cross-
link within the human genome (3 3 109 base pairs) can theoretically
impede replication and thus retard cell division. In contrast, the
likelihood for PUVA-induced photoadducts to interfere with transcrip-
tion of a particular gene is quite low, because a psoralen photoadduct
needs to be generated within the short stretch of a few kilobases
Figure 5. PUVA does not activate DNA binding of NFκB. (a) Nuclear
extracts were prepared as described in Materials and Methods from untreated cells
or from cells 1 h after PUVA treatment. Extracts were incubated with a 32P-
labeled double-stranded oligonucleotide containing an NFκB or an SP1
consensus motif. Incubation was followed by electrophoresis on a nondenaturing
polyacrylamide gel. Specific NFκB-binding complexes are marked by arrows.
Experiments with HL60 cells: lane 1, untreated controls; lane 2, PUVA (100 ng
8-MOP per ml 1 0.25 J UVA per cm2); lane 3, PUVA (500 ng 8-MOP per
ml 1 0.5 J UVA per cm2); lane 4, 10 ng TNF-α per ml (incubation for 1 h
prior to extraction). Experiments with HaCaT cells: lane 1, untreated controls;
lane 2, 500 ng 8-MOP per ml; lane 3, 1.0 J UVA per cm2; lane 4, PUVA
(500 ng 8-MOP per ml 1 0.5 J UVA per cm2); lane 5, PUVA (500 ng 8-
MOP per ml 1 1.0 J UVA per cm2); lane 6, 10 ng TNF-α per ml (incubation
for 1 h prior to extraction). (b) Competition studies with extracts from HaCaT
cells (incubated with 10 ng TNF-α per ml for 1 h prior to extraction). Lane
1, no competition; lane 2, competition with 50 ng of an unlabeled double-
stranded oligonucleotide containing an AP1 consensus-binding motif (irrelevant
DNA sequence); lane 3, competition with 50 ng of unlabeled identical double-
stranded NFκB oligonucleotide; lane 4, competition with 0.5 ng of unlabeled
identical double-stranded NFκB oligonucleotide. Specific binding complexes
are marked by arrows.
representing the transcriptional unit of a gene. Consistent with this
assumption, in this study, PUVA, at nonlethal conditions, did not
reduce mRNA levels and thus did not inhibit the transcription of two
investigated genes. The observations were made in a promyelocytic
leukemia and a keratinocyte cell line. Both neutrophils and keratinocytes
are assumed to actively synthesize and secrete proinflammatory medi-
ators during cutaneous inflammation, and from the presented data it is
not likely that PUVA inhibits inflammation by directly suppressing the
production of proinflammatory mediators.
Although it is unlikely from the presented data that PUVA therapy
directly inhibits transcription, there are indications that PUVA may
indeed increase transcription. Bernstein et al (1996) demonstrated the
activation of the human elastin promoter (in dermal fibroblasts from
transgenic mice) using therapeutically relevant PUVA doses. PUVA
was reported to increase IL-15 mRNA levels in endothelial cells,
although at lethal PUVA conditions (Mohamadzadeh et al, 1996).
Similarly, we have observed an increase of c-jun mRNA levels in
HL60 cells in response to PUVA. The molecular mechanisms for
transcriptional activation by PUVA are not defined at present.
The induction of ‘‘late response genes’’ by UV radiation of short
wavelengths is believed to be mediated by UV-induced DNA modifica-
tions (Bender et al, 1997). In analogy, psoralen-DNA photoadducts
may generate secondary intracellular signals that ultimately lead to the
activation of gene transcription. It has been hypothesized that distortions
produced by psoralen-DNA photoadducts may disrupt the native
nucleosome-DNA structure at promoters, thereby allowing transcrip-
tion factors to gain access to the gene and increase transcription
(Gasparro et al, 1997). Additionally, PUVA may, e.g., via the generation
of ROI and subsequent intracellular signaling, activate transcription
factors that in turn increase the transcription of certain genes; however,
the demonstrated lack of NFκB activation does not support the
latter view.
ICAM-1 is one of several cell surface molecules involved in the
initiation and maintenance of cutaneous inflammatory events. ICAM-
1 is upregulated by proinflammatory cytokines like TNF-α, IL-1, or
IFN-γ, but also by exogenous stimuli like ionizing radiation (Behrends
et al, 1994) and UV radiation (Norris et al, 1990; Heckmann et al,
1994; Grether-Beck et al, 1996). In this study, PUVA did not affect
ICAM-1 transcription or cell surface expression at nonlethal conditions.
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UVA alone induces ICAM-1 expression in keratinocytes or endothelial
cells (Heckmann et al, 1994; Grether-Beck et al, 1996); however,
effective doses are at least one order of magnitude higher than those
used here. Accordingly, UVA alone did not induce either ICAM-1
mRNA or cell surface expression. The lack of immediate effects of
PUVA on ICAM-1 mRNA and cell surface expression forms a striking
contrast to the immunohistologic finding that epidermal ICAM-1
expression is downregulated after successful PUVA therapy (Petzelbauer
et al, 1991) with multiple PUVA treatment sessions. This decrease of
ICAM-1 expression in vivo after PUVA may be a secondary phenom-
enon due to the PUVA-induced decrease in skin infiltrating lympho-
cytes (Vallat et al, 1994) and subsequent decreased secretion of
proinflammatory factors inducing ICAM-1. At any rate, the exact
molecular effects of repetitive PUVA treatments on cellular ICAM-1
expression in vitro remains to be determined.
The main clinical features of PUVA phototoxicity are erythema and
edema. Although psoralen-DNA photoadducts are regarded as the
crucial event leading to PUVA erythema (Ortel and Gange, 1990), the
generation of prostaglandins (Imokawa, 1989) and ROI via type-II
reactions (Carraro and Pathak, 1988; Potapenko, 1991) may also
contribute to PUVA phototoxicity. We have investigated the PUVA
effects on a prototypical ROI-responsive transcription factor, NFκB,
as an indicator for transcriptional effects of PUVA-generated ROI. At
a wide range of PUVA regimens including pharmacologically active,
yet nonlethal conditions and even already cytotoxic doses, PUVA did
not induce NFκB-binding activity in HaCaT or HL60 cells. This is
indirectly confirmed by our observation that PUVA did not influence
ICAM-1 mRNA levels, because ICAM-1 is an NFκB-regulated gene
and has been shown to be induced by ROI-activated NFκB (Baeuml
et al, 1997). Taken together, these data do not support a major role
for PUVA-generated ROI in immediate transcriptional regulation.
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